Quantcast

Latest Migraine surgery Stories

2014-09-16 23:14:34

Up until August, frustrated patients with prescriptions could not readily order and receive the Cefaly migraine treatment device efficiently. healthbeautydistributors.com as a service has shortened the ordering process for patients through its direct relationship with Cefaly manufacturer. New Jersey (PRWEB) September 16, 2014 Banish headaches forever with the newest item sold through healthbeautydistributors.com, the drug-free, FDA approved Cefaly device for chronic migraine relief and...

2014-07-09 23:03:50

NobleStitch 1 year results receive positive reviews from physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt. Fountain Valley, CA (PRWEB) July 09, 2014 Nobles Medical Technologies II (NMT2) today announced that Dr. Michael Mullen (Consultant Cardiologist at the University College Hospital and Member of the NMT2 clinical Advisory Board) presented positive results for the 1-year follow up of patients treated with NobleStitch EL PFO Closure System. NMT2...

2014-06-19 23:18:18

Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. Fountain Valley, CA (PRWEB) June 19, 2014 Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. The patient, a nurse/ administrator from the hospital and rehabilitation center in Linkoping, who has suffered from stroke and migraine was being treated with aggressive medication Warfarin (a...

2014-05-16 23:07:41

Nobles Medical Technologies II treats first US patient with NobleStitch EL PFO Closure Device. Fountain Valley, CA (PRWEB) May 16, 2014 Nobles Medical Technologies II (NMT2) today announced that its first American patient has had a successful PFO closure. John Wyall from Orem, Utah has suffered from stroke, aura, and severe chronic fatigue that has worsened in the last few years to the point that he has been bedfast for 14 to 18 hours a day for the last year and a half and unable to do...

2014-04-29 23:07:45

Nobles Medical Technologies II today announced that it has received another Japanese Patent for its NobleStitch Technology. The patent is for the Suturing Devices and Methods for Closing a Patent Foramen Ovale (PFO) and shows the broad coverage of our method and apparatus for PFO Closure expanding to markets around the world. Fountain Valley, CA (PRWEB) April 29, 2014 Ben Brosch, President of NMT2 and co-inventor on the issued patent, commented, “We strive to protect our inventions with...

2014-04-26 23:03:01

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has officially launched sales in Sweden for its NobleStitch EL PFO Closure System. NMT2 launched sales initially in Germany and the UK and will now be expanding this month into Sweden. Fountain Valley, California (PRWEB) April 26, 2014 Following a successful meeting at the Congress of Structural Interventions (CSI) congress in Frankfurt last June NMT2 received significant inquiries to bring its PFO technology to new...

2014-03-12 12:28:44

Episodic migraine patients may soon find relief from innovative medical headband NEW YORK, March 12, 2014 /PRNewswire/ -- CEFALY Technology announced today that its received U.S. Food and Drug Administration (FDA) approval of the Cefaly® medical device for the preventative treatment for migraine headaches. Cefaly® is the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use prior to the onset of pain. It is expected to be available in the...

Cefaly for migraines
2014-03-12 11:06:45

Brett Smith for redOrbit.com - Your Universe Online In a statement released on Tuesday, the Food and Drug Administration announced the approval of the first-ever medical device made to prevent migraines. Called Cefaly, the device is shaped like a tiara and delivers a “tingling” electric current to the wearer’s forehead. According to a report published in the journal Neurology last month, Cefaly decreased chronic migraine onset by two per month on average, and 38 percent of users...

2014-01-08 08:29:41

The scientific journal "JOURNAL of HEADACHE and PAIN" publishes positive results from a clinical study conducted on 2,313 patients which confirms the high efficacy and safety of the medical device CEFALY ® migraine treatment LIEGE, Belgium, January 8, 2014 /PRNewswire/ -- http://www.thejournalofheadacheandpain.com/content/14/1/95 The efficacy and safety of the CEFALY (R) medical device for migraine treatment had already been reported early 2013 in the scientific journal...

2014-01-08 08:28:02

SAN MATEO, Calif., Jan. 8, 2014 /PRNewswire/ -- Labrys Biologics Inc., a biotechnology company focused on treatments for migraine, today announced that patients are now being enrolled in two separate Phase 2b clinical studies of LBR-101 (formerly RN-307) as a subcutaneous once-monthly treatment for the prevention of frequent migraines. The first study is enrolling subjects with chronic migraine, who experience at least 15 headache days per month. The second study is enrolling subjects...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.